These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1022 related items for PubMed ID: 8636768

  • 1. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.
    Martelli M, Vignetti M, Zinzani PL, Gherlinzoni F, Meloni G, Fiacchini M, De Sanctis V, Papa G, Martelli MF, Calabresi F, Tura S, Mandelli F.
    J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768
    [Abstract] [Full Text] [Related]

  • 2. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Santini G, Salvagno L, Leoni P, Chisesi T, De Souza C, Sertoli MR, Rubagotti A, Congiu AM, Centurioni R, Olivieri A, Tedeschi L, Vespignani M, Nati S, Soracco M, Porcellini A, Contu A, Guarnaccia C, Pescosta N, Majolino I, Spriano M, Vimercati R, Rossi E, Zambaldi G, Mangoni L, Rizzoli V.
    J Clin Oncol; 1998 Aug; 16(8):2796-802. PubMed ID: 9704732
    [Abstract] [Full Text] [Related]

  • 3. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial.
    Martelli M, Gherlinzoni F, De Renzo A, Zinzani PL, De Vivo A, Cantonetti M, Falini B, Storti S, Meloni G, Rizzo M, Molinari AL, Lauria F, Moretti L, Lauta VM, Mazza P, Guardigni L, Pescarmona E, Pileri SA, Mandelli F, Tura S.
    J Clin Oncol; 2003 Apr 01; 21(7):1255-62. PubMed ID: 12663712
    [Abstract] [Full Text] [Related]

  • 4. PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients).
    Philip T, Chauvin F, Bron D, Guglielmi C, Hagenbeek A, Coiffier B, Gisselbrecht C, Kluin Nelemans JC, Somers R, Misset JC.
    Ann Oncol; 1991 Jan 01; 2 Suppl 1():57-64. PubMed ID: 2043500
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease.
    Brandwein JM, Callum J, Sutcliffe SB, Scott JG, Keating A.
    Bone Marrow Transplant; 1990 Feb 01; 5(2):99-103. PubMed ID: 2310878
    [Abstract] [Full Text] [Related]

  • 6. Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.
    Philip T, Chauvin F, Armitage J, Bron D, Hagenbeek A, Biron P, Spitzer G, Velasquez W, Weisenburger DD, Fernandez-Ranada J.
    Blood; 1991 Apr 01; 77(7):1587-92. PubMed ID: 2009374
    [Abstract] [Full Text] [Related]

  • 7. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA, Miller TP.
    N Engl J Med; 1993 Apr 08; 328(14):1002-6. PubMed ID: 7680764
    [Abstract] [Full Text] [Related]

  • 8. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
    Zinzani PL, Martelli M, Magagnoli M, Zaja F, Storti S, Pavone E, Lauta VM, De Renzo A, Gobbi M, Bocchia M, Ronconi F, Scaramucci L, Gherlinzoni F, Palombi F, Bendandi M, Stefoni V, Anticoli Borza P, Cellini C, Mandelli F, Tura S.
    Haematologica; 1999 Nov 08; 84(11):996-1001. PubMed ID: 10553159
    [Abstract] [Full Text] [Related]

  • 9. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Sertoli MR, Santini G, Chisesi T, Congiu AM, Rubagotti A, Contu A, Salvagno L, Coser P, Porcellini A, Vespignani M.
    J Clin Oncol; 1994 Jul 08; 12(7):1366-74. PubMed ID: 7517442
    [Abstract] [Full Text] [Related]

  • 10. Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study.
    Kluin-Nelemans HC, Zagonel V, Anastasopoulou A, Bron D, Roozendaal KJ, Noordijk EM, Musson H, Teodorovic I, Maes B, Carbone A, Carde P, Thomas J.
    J Natl Cancer Inst; 2001 Jan 03; 93(1):22-30. PubMed ID: 11136838
    [Abstract] [Full Text] [Related]

  • 11. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N.
    Bone Marrow Transplant; 2000 Nov 03; 26(9):971-7. PubMed ID: 11100276
    [Abstract] [Full Text] [Related]

  • 12. MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
    Mazza P, Zinzani PL, Martelli M, Fiacchini M, Bocchia M, Pileri S, Falini B, Martelli MF, Amadori S, Papa G.
    Leuk Lymphoma; 1995 Feb 03; 16(5-6):457-63. PubMed ID: 7540460
    [Abstract] [Full Text] [Related]

  • 13. High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.
    Josting A, Sieniawski M, Glossmann JP, Staak O, Nogova L, Peters N, Mapara M, Dörken B, Ko Y, Metzner B, Kisro J, Diehl V, Engert A.
    Ann Oncol; 2005 Aug 03; 16(8):1359-65. PubMed ID: 15939712
    [Abstract] [Full Text] [Related]

  • 14. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Jost LM, Jacky E, Dommann-Scherrer C, Honegger HP, Maurer R, Sauter C, Stahel RA.
    Ann Oncol; 1995 May 03; 6(5):445-51. PubMed ID: 7545428
    [Abstract] [Full Text] [Related]

  • 15. Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
    Cabanillas F, Velasquez WS, McLaughlin P, Jagannath S, Hagemeister FB, Redman JR, Swan F, Rodriguez MA.
    Semin Hematol; 1988 Apr 03; 25(2 Suppl 2):47-50. PubMed ID: 3041599
    [Abstract] [Full Text] [Related]

  • 16. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.
    Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK.
    J Clin Oncol; 1992 Dec 03; 10(12):1949-54. PubMed ID: 1453209
    [Abstract] [Full Text] [Related]

  • 17. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N.
    Cancer Invest; 2008 May 03; 26(4):401-6. PubMed ID: 18443961
    [Abstract] [Full Text] [Related]

  • 18. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V.
    Haematologica; 2000 Feb 03; 85(2):160-6. PubMed ID: 10681723
    [Abstract] [Full Text] [Related]

  • 19. Non-hodgkins lymphoma.
    Mead G, Woodcock J, Young C.
    Clin Evid; 2003 Jun 03; (9):1-21. PubMed ID: 12967352
    [No Abstract] [Full Text] [Related]

  • 20. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
    Zinzani PL, Barbieri E, Visani G, Gherlinzoni F, Perini F, Neri S, Bendandi M, Ammendolia I, Salvucci M, Babini L.
    Haematologica; 1994 Jun 03; 79(6):508-12. PubMed ID: 7534744
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.